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In vitro translation using both free and membrane bound polysomes as 
the source of mRNA, have shown that (4-5 day old) embryonic chick brain 
hyaluronidase is synthesized at both subcellular locations. These forms, 
however, are distinctly different in regards to their molecular weight, co- 
and post-translational modification requirements and in their ultimate 
sites of function within the cell itself. The form synthesized on free 
polysomes is approximately 72,000 Mr and the form synthesized on membrane 
bound polysomes is approximately 68,000 Mr and is post translationally 
modified to its authentic form of 70,000 Mr in the lysosomes. This evi¬ 
dence strongly suggests that two forms of embryonic chick brain hyaluroni¬ 
dase exist. One form is soluble and present in the cytosolic fraction, 
and one is both secretory and present in the lysosomes. 
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CHAPTER I 
INTRODUCTION 
Hyaluronidase (Hyaluronate glycanohydrolase, EC 3.2 1.35) is the 
collective name for a group of endo^-hexosaminidases which hydrolyze 
(1-4) hexosaminido glucoronic acid bonds of hyaluronic acid to yield, at 
first, high molecular weight oligosaccharides and later a tetrasaccharide 
(Margolis et^ aj_, 1972). In addition hyaluronidase degrades chondroitin 
4 and 6 - sulfate and chondroitin, but at a considerably slower rate. 
Hyaluronic acid is a glycosaminoglycan which consists of repeating 
disaccharide units of^ D-glucoronic acid and N-acetyl D-glucosamine. 
Hyaluronic acid as well as some other glycosaminoglycans (formerly termed 
acid mucopolysaccharides) are degraded by the concerted actions of endo- 
and exoglycosidases. In the case of hyaluronic acid, it is degraded by 
hyaluronidase which allows further degradation by exoglycosidases into 
it's monosaccharide components (Meyer, 1971; Margolis et al_, 1972). 
The most extensively studied form of hyaluronidase has been isolated 
from the testis. Hyaluronidase has also been isolated from numerous 
mammalian tissues including rat liver, skin and brain; bovine brain and 
aorta, as well as chick embryo heart, brain and muscle fibroblasts. 
(Bollet et^ aj_, 1963; Vaes, 1967; Aronson and Davidson, 1967; Orkin and 
Toole, 1978; Waiindi, 1980). 
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These forms of hyaluronidase differ from testis hyaluronidase in 
that they exhibit an acid pH optimum, whereas the testis hyaluronidase 
is active over a broad pH range (Vaes and Jacques, 1965; Aronson and 
Davidson, 1967). 
Hyaluronic acid (from this point termed hyaluronate, in contrast 
to the sulfated glycosaminoglycans, may not exist as a proteoglycan but 
as an individual glycosaminoglycan in the extracellular matrix. (Toole, 
1984). The immense size and negative charge of hyaluronate induces each 
molecule in solution to form an extended random coil which, in concen¬ 
trated solutions, begins to overlap causing molecules to entangle. Thus, 
at physiological conditions a dense meshwork exists which has the 
capacity to restrict the flow of water, interfere with the diffusion 
of macromolecules, thereby excluding nutrients from the meshwork (Toole 
and Linsenmayer, 1977). The presence of hyaluronate and its subsequent 
removal by hyaluronidase plays an important role in the regulation of 
morphogenesis and differentiation in embryonic systems (Toole, 1973; 
Polansky, 1974; Knudson and Toole, 1985). 
The accumulation of cells via migration or proliferation has been 
correlated with the synthesis of hyaluronate in the chick axial skeleton 
and cornea. One example of the widespread correlation between hyaluro¬ 
nate synthesis and increased extracel lular matrix volume can be seen in 
embryonic neural crest cells. These cells initially migrate into the 
cell free space between head ectoderm and mesoderm (Pratt et^ al_, 1975). 
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During gastrulation hyaluronidase first becomes detectable at approxi¬ 
mately stage 25 (3-4 days) of development and its activity is pronounced 
through stage 36 (Toole, 1971; Toole and Linsenmayer, 1977). It appears 
that the hyaluronidase activity begins at the stage of development 
when a number of morphogenetic activities such as mesodermal cell accumu¬ 
lation take place. This activity increases at the end of active cell 
migration and proliferation, which supports the hypothesis that high 
hyaluronate levels suppress differentiation until the appropriate time 
for development of a particular tissue (Toole, 1973). This sequence of 
events at the beginning of skeletogenesis is marked by a hyaluronate-rich 
extracellular matrix. This matrix provides a favorable environment for 
undifferentiated cells and prevents precocious intercellular communica¬ 
tion, thus, preventing differentiation (Toole and Linsenmayer 1977). At 
the end of the migratory phase of morphogenesis the appearance of hya¬ 
luronidase becomes detectable. Hyaluronidase degrades hyaluronate and 
allows for the differentiation of cells to occur (Toole and Gross, 1971; 
Toole, 1972; Toole, 1984). Embryonic chick fibroblasts have been reported 
to produce two forms of hyaluronidase. One form is associated with the 
cells and one is secreted into the medium (Orkin and Toole, 1980). The 
secreted form possesses a greater thermal stability at a neutral pH than 
the cellular form. Treatment of the secreted form with neuraminidase 
caused a shift in properties closer to those of the cellassociated form 
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(Orkin and Toole, 1980). The vast majority of studies have concentrated 
on the activity of hyaluronidase and have not focused on it's physical 
characteristics or it's biosynthetic requirements. 
In this laboratory we have begun to identify chick embryo brain 
hyaluronidase from stage 24-26 (4-5 days old) chicks and attempted to 
determine the site or sites of biosynthesis. We have studied the co- 
translational requirements of the enzyme and it's putative relationship 
to the two forms of hyaluronidase previously identified. Experimental 
evidence for the synthesis of two forms of hyaluronidase is shown. One 
form is synthesized on membrane-bound polysomes and is vectored into the 
lumen of the rough endoplasmic reticulum where core glycosylation, pre¬ 
sumably, takes place. From this point it is expected that this form is 
vectored through the entire endomembrane system and localized in the 
lysosomes. The second form is synthesized on free polysomes and vectored 
into the cytoplasm. 
CHAPTER II 
REVIEW OF LITERATURE 
The first references to the enzyme hyaluronidase were made in 1936 
when Menkin reported a substance from inflammatory exudates which appar¬ 
ently increased the permeability of rabbit capillaries. He termed 
it “Leikotoxine" because it caused an accumulation of leukocytes around 
the areas injected (Menkin, 1936). In 1939 investigators obtained similar 
results from minced liver, kidney, muscle and skin. They named this sub¬ 
stance "Permeability Increasing Factor." In addition, it was found that 
extracts containing hyaluronidase from testis and bacterial filtrates 
increased permeability of the dermal layer of skin. Investigators 
suggested that the skin contains some substrate for an enzyme present in 
the filtrates. They subsequently attempted to purify the enzyme and 
showed its ability to act on a synovial fluid, vitreous humor and umbili¬ 
cal cord preparations (Duthie and Chain, 1939). Duthie suggested that 
the enzyme splits polysaccharides into simple sugars. Thus, the name, 
"polysaccharide splitting enzyme," became common. In 1941 this enzyme 
was isolated from the leech and was shown to have a decapsulation effect 
on a virulent strain of streptococcus. Hirst also reported a protective 
effect on mice infected with the virus (Hirst, 1941). 
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In 1942 McLean was unable to obtain decapsulation i£ vivo, although 
he was able to demonstrate it jhn vitro. He showed that the protective 
effect of the enzyme on mice is negligible since it is inhibited by 
starch, gum accacia, heparin, gastric mucin, chondroitin sulfate and 
whole blood (McLean, 1942) 
Most research beyond this point has been directed towards charac¬ 
terization and purification of hyaluronidase from various sources, or 
the assessment of its biological activity on substrates such as 
hyaluronic acid, chondroitin sulfate, heparin and other related sub¬ 
strates. Weissman (1955) and Houck and Pearce (1957) partially purified 
and characterized bovine testis hyaluronidase and ten years later Aronson 
and Davidson (1967) purified and characterized rat liver tissue 
hyaluronidase. Similarly, Margolis (1967) isolated hyaluronidase from 
bovine brain and demonstrated its activity on hyaluronate and chondroitin 
sulfate. The enzyme was identified in human, sheep, chicken, monkey, 
rat and rabbit brain in 1967 by Singh and Bacchawat. It was later 
reported that hyaluronidase degraded hyaluronate to oligosaccharides 
with N-acetyl glucosamine at its reducing end (Aronson and Davidson, 
1967). With the assessment of the enzymatic function of hyaluronidase, 
researchers have shifted their efforts to determining the role of the 
biological degradation of hyaluronate in the vast number of systems in 
which it is found. 
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Hyaluronidase has been of great interest in the study of embryonic 
development. The development of embryonic systems is characterized by 
high levels of hyaluronidase activity and increased hyaluronate concen¬ 
tration, both of which decline as development advances (Toole and Gross, 
1971; Polansky, 1974). Similar results, obtained from chick heart (Orkin 
and Toole, 1978), coincide with studies performed on regenerating newt 
limb in which hyaluronidase activity declines as development continues 
(Toole and Gross, 1971). This led researchers to postulate a determinate 
role for hyaluronate in development. They suggested that hyaluronate 
allows for the accumulation of cells and acts to prevent untimely cellular 
interactions prior to tissue formation. This effect is removed by 
hyaluronidase at the appropriate time for differentiation to take place 
(Toole and Linsemayer, 1977; Pratt ert aj[, 1975). In 1975 Pratt et^ al_ 
observed that cranial neural crest cells migrated into the cell free 
space between the head ectoderm and mesoderm. This space was found to 
be rich in hyaluronate, which suggested an affinity of undifferentiated 
cells for hyaluronate. Several investigators isolated the enzyme in 
bone tissue and determined that its in situ position was lysosomal 
(Aronson and Davidson, 1967; Margolis, 1972). 
The nature of lysomal enzymes, as well as their glycoprotein 
character, has led researchers to suggest a similarity between lysosomal, 
membrane and secretory proteins (deDuve and Wattiaux, 1966; Rosenfeld et 
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al, 1982). The similarity lies in the presumption that lysosomal, mem¬ 
brane and secretory proteins all bear transient amino terminal sequences 
that serve as signals for co-translational insertion into endomembranes. 
These signals are cleaved upon the nascent polypeptides' entry into the 
lumen of the endoplasmic reticulum (Blobel and Dobberstein, 1975; Jackson 
and Blobel 1977; Blobel, 1980). Lysosomal enzymes have been reported to 
undergo the same post translational processing and proteolytic cleavage 
as membrane proteins and secretory proteins (Erickson and Blobel, 1979). 
They pass through the smooth endoplasmic reticulum and ultimately the 
golgi apparatus. At this point the lysosomal enzymes are sequestered in 
vesicles and secured in primary lysosomes. In 1980, Orkin and Toole 
suggested that two forms of hyaluronidase exists; one secretory and one 
associated with the cells. These investigators have reported that the 
differences lie in the greater number of sialic acid residues present on 
the secreted form. 
Many investigators have studied the secretion and reinternalization 
of lysosomal hydrolases. One theory is based on the necessity of a 
specific receptor that mediates the recapture of lysosomal enzymes. 
(Neufeld et^a^, 1977; Sando and Neufeld, 1977). A second hypothesis states 
that the phosphomannosyl marker is involved in segregating proteins that 
are to be retained in lysosomes. This concept involves the synthesis of 
lysosomal enzymes and their passage through the rough and smooth endo- 
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plasmic reticulum and then to the golgi apparatus. There they are concen¬ 
trated into primary lysosomes. The phosphomannosal marker causes the 
enzyme to bind to the walls of exocytotic vesicles during eversion, and 
fuse with the plasma membrane, thereby allowing for the secretion of 
unbound material (Kaplan et al_, 1977; Neuf eld et^ al_, 1977). The existence 
of multiple forms of lysosomal enzymes has been shown (Robinson, 1974). 
Cytosolic forms of these enzymes have also been demonstrated (Kanfer 
et al_, 1975; Glew et al_, 1976). An explanation for the role of lysosomal 
and extralysosomal proteins within the cell has not yet been convincingly 
presented. Some researchers have postulated that this arrangement may 
provide some sort of feedback mechanism to control synthesis of the 
lysosomal enzymes. Hyaluronidase may exist as two forms which have 
different co-and post-translational modification requirements for core 
and terminal sugars, as well as, co-translational requirement for membrane. 
We are attempting in our laboratory to address the questions of multiple 
forms of hyaluronidase. In addition we are attempting to determine 
the site or sites of synthesis using jjn vitro synthesis techniques. 
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Biomedical Significance 
The role of hyaluronidase in morphogenesis and differentiation in 
embryonic systems has been documented (Toole and Linsenmayer, 1977). 
The degradative capacity of hyaluronidase on the glycosaminoglycans, 
hyaluronic acid and chondroitin sulfate has led researchers to observe 
the possible abnormalities that may occur in systems as result of a 
deficiency in the enzyme. A number of disease states have been attribut¬ 
ed to improper degradation of some of the glycosaminoglycans. Hurlers, 
Hunter's, and Marfans disease as well as Sanfilippo's syndrome are all 
pathologic conditions resulting from an accumulation of gycosamino gly- 
cans. All of these are genetic in nature and produce various physical 
and mental retardations. Hurler's syndrome is caused by an accumulation 
of dermatan and heparin sulfate in connective tissue, golgi, spleen, 
brain and kidney (Meyer et al_, 1957). Cultured human skin fibroblasts 
of patients with Hurler's disease have been shown to accumulate high 
levels of hyaluronic acid. A similar situation has been shown in 
Marfans disease (Matalon and Dorfman, 1966). These disease states seem 
to be due to the improper control of glycosaminoglycan synthesis. 
The I Cell disease in man results from a defect in lysosomal 
glycosidases. An elevated level of lysosomal glycosidases have been 
found in the medium of cultured fibroblasts from patients with I Cell 
disease. (Hickman and Neufeld, 1972). 
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This is most probably due to the over secretion of lysosomal exoglycosi- 
dases or the lack of retention of the primary lysosomal enzymes them¬ 
selves (Hickman et aj^, 1974; Vladutiu, 1978). This disease state, again, 
addresses the question of whether or not lysosomes are secreted and 
endocytosed or retained within the cell. Tay Sachs disease, a disorder 
commonly associated with the Jewish community, is marked by an absence 
of one form of the enzyme hexosaminidase (Srivasta and Beutler, 1973). 
In Fabry's disease the alpha galactosidase enzyme is deficient, and in 
gangliosidosis the beta gal actosidase enzyme is absent (Mapes et al_, 
1970). The existence of these syndromes leads to the question of whether 
or not isoenzymes of lysosomal hydrolases play a role in the occurence 
of the various lysosomal disease states. As stated above, many lysosomal 
enzymes exist in multiple forms. These forms may be the product of 
several different genes, multiple alleles or different post-translational 
modifications (Robinson, 1974). In the case of some lysosomal enzymes, 
one form is active at an acidic pH while the other form is active at a 
pH closer to neutrality (Carrol et et, 1972), e.g. alpha mannosidase. 
When the synthesis of the acidic form is blocked genetically the neutral 
form is not affected at all (Carroll et al_, 1972; Phi 11 ips et al_, 1974). 
This strongly suggests that the enzymes are of independent origins. 
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Although the various lysosomal storage diseases are significant 
features of lysosomal enzyme synthesis, hyaluronidase may play it's 
major role in the disorders involved in improper brain development. 
In Cranioschisis morphogenesis of the brain is completely absent. 
While microcephaly and macrocephaly are conditions marked by under and 
oversized brain development, respectively. The study of hyaluronic acid 
and hyaluronidase involvement in developmental systems may serve to 
answer some of the questions raised concerning abnormal development. 
The role of two possible forms of hyaluronidase in regulation of develop¬ 
ment or in regulation of synthesis of lysosomal enzymes is presently 
being studied in our laboratory. This paper will attempt to address the 
site and/or sites of synthesis of chick embryo hyaluronidase. 
CHAPTER III 
MATERIALS AND METHODS 
The methods employed in this investigation essentially involved the 
preparation of whole embryonic chick brains, isolation of free and mem¬ 
brane bound polysomes, and i_n vitro translation using free and membrane 
bound polysomes to determine the site of synthesis of chick brain hya- 
luronidase. Embryonic chick brain fluid was provided as a gift from Dr. 
Eluid Waiindi (University of Nairobi, Nairobi, Kenya). 
Preparation of Chick Brains 
Embryonated eggs of the White Leghorn Kimber strain (Haley Farms 
Canton, GA) were incubated at 37°C to obtain serial stages of development 
(Hamburger and Hamilton, 1951). At 4-5 days of incubation (stage 25) the 
eggs were removed from the incubator and opened in physiological saline. 
The brains were surgically removed under the dissecting microscope and 
placed into 50 ml conical tubes containing saline. Approximately 10 
dozen chick eggs were used in each experiment. 
Subcellular fractionation of Chick Brain Tissue 
Approximately 6 grams of embryonic chick brains were placed in 4 
volumes of cold homogenate buffer containing 85% sucrose, triethanolamine 
pH 7.4, 2M KCL 1M MgCl£ (STKM). The tissue was then homogenized using 
a glass hand held homogenizer for 30 up and down strokes. The cell 
homogenate was placed in two 50 ml conical tubes and centrifuged for 5 
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minutes at 4°C at 4,000 xg RPM in an IEC (International Equipment Company) 
PR 6000 centrifuge. The supernatant (post nuclear supernatant; PNS) was 
collected and the pellet discarded. The PNS was then centrifuged for 10 
minutes at 20,000 xg for 10 minutes in a Beckman J2-21 centrifuge at 
4°C in a type 20 rotor. The pellet (containing the mitochondrial and 
lysosomal fractions) was quick frozen in liquid nitrogen and stored at 
-80°C. The supernatant (post mitochondrial supernatant; PMS) was lay¬ 
ered over a discontinuous gradient of 1.3, 1.5, and 2.0M Sucrose. The 
PMS was centrifuged at 105,000 xg for 24 hrs at 4°C in a Beckman L8-70 
ultracentrifuge in a Type 42.1 rotor. The rough microsomal layer 
(membrane bound polysomes) appeared as a yellowish brown layer at the 
1.5M and 2.0M interphase and the free polysome fraction appeared as a 
pellet at the bottom of the tube. The free polysomal fraction was 
resuspended in 1 ml of sterile distilled H2O and the rough microsomal 
layer was collected using a sterile 1 cc syringe (Adelman, Blobel and 
Sabatini, 1973). Aliquots of both fractions were analyzed spectropho- 
tometrically at 260 nm in a Beckman Du 8 spectrophotometer and RNA 
determinations were performed (Fleck and Munro, 1962). The cytosolic 
fraction was obtained by collecting the supernatant above the 1.3 M 
interphase (See figure 1). Fractions that were not immediately used in 
in vitro translations were quick frozen in liquid nitrogen and stored 
-80°C. 
Fig. 1. Isolation of free and membrane bound polysomes. All steps 
performed at 4°C. 
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Chick Brains 
Homogenize 30 up/down 
strokes in 0.25M STKM* 
buffer 
Homogenate 
Centrifuge 6000 RPM 
5 min. in IEC centrifuge 
Supernatant  > Discard Pellet 
Centrifuge 10,000 RPM 
10 min. J2-20 rotor 
Supernatant 
Layer supernatant 
over 1,3, 1.5 and 
2.0 M STKM dis¬ 
continuous gradient 
Mitochondrial + 
’-> Save Pellet Lysosomes 
Ultra Centrifuge 
40,000 RPM for 
24 hrs in a type 42.1 
rotor 
Aspirate Supernatant 
Above 1.3 M interface 
Contains cytosol 
Aspirate yellow brown 
layer at 1.5/2.0 M 
interface. 
Membrane bound polysomes 
Resuspend pellet in 
distilled H2O and 
store at -80°C. 
Contains free polysomes 
*Homogenate buffer contains 85% sucrose, 2M KCL, 1M TEA, ph 7.4, 
1M MgCl2, dH20. 
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In Vitro Translation Experiments 
Incorporation of 35s-Methionine into protein was performed in a 
rabbit reticulocyte lysate cell-free translation system (Promega Bio- 
logicals Madison, Wisconsin). Twenty-five microliter total transla¬ 
tion mixtures contained 2 ul distilled H2O, 2 ul free or membrane 
bound polysomes, 5 ul energy mixture (0.1M ATP, 0.2M GTP, 0.6M, 10 UC3 
5 S-Methionine (Amersham Arlington, Illinois) 8mg/ml CPK (creatine phos- 
pho kinase) and distilled H2O), 2.5 ul compensation buffer (1M Tris-HCL 
pH 7.4, 0.4M KCL, 1M MgCl2 and distilled H2O), and 12.5 ul of micrococcal 
nuclease digested lysate. The lysate mixtures were digested by adding 2 
ul of micro coccal nuclease per 100 ul of lysate and 1 ul of 1M CaCl2 
per 100 ul of lysate to be digested. The lysate mixtures were incubated 
at room temperature for 12 minutes. The reaction was then terminated 
upon the addition of 0.1M EGTA. Total jn_ vitro translation mixtures 
were incubated in a 29°C water bath for 59 minutes (Pelham and Jackson, 
1976). 
Co-translational Processing and Post- 
translational Proteolysis Experiments 
Both free and membrane bound polysomes were used as the source of 
mRNA for i_n vitro translation. In some cases free polysomal fractions 
in the presence of ribosomally stripped dog pancreatic membrane (DPM) 
were employed to monitor putative polypeptide insertion into membrane. 
To determine post-translational proteolysis of cytoplasmically exposed 
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proteins, 5 ul of trypsin and chymotrypsin, 80 ug/ml each, were added to 
the appropriate translation mixture immediately following translation. 
Proteolysis was performed at 0°C for 3 hours and terminated upon the 
addition of 20 ul of trasylol according to Rosenfeld et jil_, 1982. 
Scintillation Spectrophotometric Analysis of In Vitro 
Incorporation of ^S-Methionine into Translation Products 
Five ul samples from each in vitro translation reaction were micro- 
pipetted onto Whatman filter discs for scintillation counting. The 
filter discs were placed in chilled 10% TCA (trichloroacetic acid) for 
10 minutes. They were then placed in fresh 5% TCA and boiled for 3 
minutes. The discs were then saturated with ethanol: ether (50:50 ratio) 
for 15 minutes. They were then placed in ethyl ether for 15 minutes. 
The discs were subsequently dried and placed in 5 ml of toluene based 
scintillation fluid (aquafluour) and counted in a Beckman LS 7500 
scintillation counter. 
Induction and Preparation of Antiserum to Hyaluronidase 
Embryonic chick brain fluid hyaluronidase (2 mg) was emulsified in 
Complete Freunds Adjuvant and injected into male Pasteurella free rabbits 
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(Hazelton Labs, Dutchland, Pa.) intradermally every 10 days for 30 days. 
Rabbits were bled via the marginal ear vein. Antiserum was prepared by 
allowing non-heparin treated veinous blood from the rabbits ear vein to sit 
at room temperature until clotting occurred. The clots were released 
from the walls of the conical tube and the sample was centrifuged at 
6000 xg for 10 minutes at 4°C in an IEC centrifuge. The supernatant 
was centrifuged for 10 minutes at 20,000 xg in a Beckman J2-21 centri 
fuge using a Type 20 rotor. Sodium azide was added to 2% (w/v). 
Ouchterlony Immunodiffusion Methodology 
Agarose medium (2%) was made up in 0.8% borate buffered saline, 
pH 7.5, containing 0.01% merthiolate and 0.02% trypan blue. The medium 
was poured into petri dishes and allowed to solidify. A center well and 
six surrounding wells were prepared. Antiserum (50 ul) was added to 
the center well, while lysosomal and cytosolic fractions (200 ul), or 
saline were placed in the remaining wells. The plates were incubated at 
37°C for 1-3 days (Ouchterlony, 1963). 
Immunoprécipitation From In Vitro Translation Products 
Total free polysomal, free polysomes plus dog pancreatic mem¬ 
brane (Shields and Blobel, 1978), membrane bound polysomes, and 
fractions treated with trypsin and chymotrypsin, post-translationally 
were each used for immunoprécipitation experiments. Trasylol (10 ul) 
and SDS (up to 2%) were added to each sample. Samples were boiled 
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for 2 minutes and cooled. Four volumes of 1.25% triton X buffer (1M 
tris pH 7.4, 2M NaCl, 0.2M EDTA, 20% triton X-100) were added to each 
sample. Five ul of monospecific rabbit anti-chick brain fluid 
hyaluronidase antiserum was added to the respective samples. They 
were then centrifuged for 30 seconds at 15,000 xg in an Eppendorf 
microfuge. The tubes were incubated in a 37°C water bath for 1 hr and 
placed in the cold room at 4°C overnight. Protein A sepharose (20 ul) 
was added to each tube and incubated for 12 hr on a BBL (cat. No. 60448) 
(Scientific Equipment Product Baltimore, MD). The samples were then 
centrifuged for 2 minutes in the eppendorf microfuge. The supernatant 
was aspirated off and the pellet washed 4 times in Triton X buffer. To 
the final pellet from the triton X washes, 50 ul of 4% SDS was added and 
the mixture was boiled for 2 minutes and then cooled. The samples were 
centrifuged for 3 minutes and the supernatant was prepared for gel 
loading (Goldman and Blobel, 1978). 
Fluorography of 10% SDS Polyacrylamide Gels 
Ten percent polyacrylamide gels were run for 17 hrs (Laemmli, 1970) 
on an ISC0 (Instrumentation Specialties Company) power supply at 22 
milliampères. At the completion of the run the gel was placed in fixa¬ 
tive solution for 3 hr and then soaked in 500 ml dimethyl sulfoxide 
20 
(DMSO) for 3 hr. This solution was poured off and the gel was immersed 
in 500 ml of distilled H2O for 1 hr. The gel was then dried on a 
vacuum dryer overnight and was then exposed to Kodak RP X-0mat Medical 
X-Ray film for 5 days, in absolute darkness in a Revco freezer at -80oc 
(Bonner and Laskey, 1974). 
Determination of Molecular Weight 
Molecular weight standards (Pharmacia Piscataway, New Jersey) were 
solubilized in 4% SDS and resuspended in loading buffer containing 5mM 
EDTA, 0.02% bromophenol blue, 42.5% sucrose, 0.1M Tris base, 20% SDS and 
1 M DTT. Molecular weight standards were run on 10% SDS polyacrylamide 
gels directly adjacent to respective samples. The relative mobilities 
of known molecular weight proteins were determined using the formula as 
described by Weber and Osborn (1967). 
Preparation of Proteins For Gel Electophoresis 
Protein containing samples used for electrophoresis were precipi¬ 
tated with cold 10% TCA for 30 minutes at 4°C. The samples were 
centrifuged at 15,000 RPM for 30 seconds. The pellet was resuspended in 
loading buffer and sonicated. The sample was then boiled for 2 minutes, 
cooled 0.25M iodoacetamide was then added and the mixture was incubated 
for 20 minutes at 37°C. The gels were loaded and run for 17 hr. Gels 
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were stained with Comassie brilliant blue and destained with methanol - 
and acetic acid. In cases where minute quantities of protein were used 
the silver stain technique was employed (Morissey, 1982). 
Assay For Hyaluronidase Activity 
Crude lysosomal and cytosolic fractions were dissolved in small 
quantities of formate buffer (0.1M sodium formate, 0.15M sodium chloride, 
0.1% Triton X-100, pH 3.7). The fractions were then transferred to screw 
tight glass test tubes containing 0.5 ml umbilical cord hyaluronic acid 
(Sigma Chemical Company, St. Louis, MO) made up in formate buffer (10 mg 
hyaluronate/ml buffer). Samples were incubated in a 37°C water bath 
routinely for 8 hrs. Hyaluronidase activity was assayed spectropho- 
tometrically according to the method of Reisseg et al (1955) by measuring 
the release of terminal N-acetyl glucosamine from hyaluronic acid. All 
absorbance readings were determined at 544nm on a Beckman DU 8 spectro¬ 
photometer. The optical density units were then converted to concentra¬ 
tions of N-acetyl glucosamine released. Samples containing no enzyme 
were used as blanks. Samples containing no substrate were used as 
negative controls, and samples containing bovine testis hyaluronidase 
(Sigma) were used as positive controls. Ammonium sulfate precipitated 
(35% and 65%) fractions followed by con A chromatography were assayed 
under the same conditions and the specific activity determined. 
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Specific activity was measured in units per mg protein (Polansky 
et al, 1974). 
Concanavalin A Sepharose Chromatography 
Concanavalin A Sepharose chromatography was performed using a 0.7 
x 0.2 cm column. Con A sepharose was equilibrated with 0.1M sodium 
formate buffer containing 0.15 NaCl and 0.1% Triton X-100, pH 3.7. 
Ammonium sulfate precipitated fractions (up to 65%) from the crude lyso¬ 
somal and cytosolic fractions were applied to the column following dialy¬ 
sis against the same buffer. Polypeptides bound to the column were eluted 
with 0.1% alpha methyl mannoside prepared in formate buffer, pH 3.7. 
Binding and nonbinding fractions were prepared for electrophoresis and 
and applied to 10% SDS polyacrylamide gels for analysis (Reinwald et al, 
1981). 
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Isolation of Hyaluronidase from Lysosomal 
and Cytosolic Fractions 
The lysosomal pellet was resuspended in distilled H2O and protein 
determinations made. Both the lysosomal and cytosolic fractions 
(200 ug/ml ) were precipitated with ammonium sulfate up to 35% and 65%, 
respectively, for 6 hr at 4°C. The samples were then centrifuged at 
15,000 xg for 3 minutes. For the lysosomal fraction the supernatant was 
saturated up to 65% with ammonium sulfate. The supernatant was then 
centrifuged for 3 minutes and the pellet resuspended in distilled H2O. 
Samples was dialyzed against formate buffer. Aliquots of the samples 
were assayed for hyaluronidase activity and used for gel electrophoresis 
and Concanavalin A chromatography or stored at - 80°C (See fig. 2.) 
Determinations of Protein Concentration 
Total protein determinations were performed according to the method 
of Lowry et al_. (1951). 







Homogenize in STKM 
Buffer 
Centrifuge at 10,000 xg 
for 5 min. 
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for 10 min. 
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triton X-100 
Ammonium sulfate pre¬ 
cipitate up to 65% over 
night. 
Centrifuge solution at 
15,000 xg for 3 min. 





In Vitro Translation Experiments 
Free and membrane-bound polysome fractions containing 75.6 absorb¬ 
ance units per ml and 15.7 absorbance units per ml, respectively, at 260 
nm were employed in i_n vitro translation experiments. These absorbance 
units correspond to 2.42 mg/ml and 0.51 mg/ml, respectively. To deter¬ 
mine the volume of free or membrane-bound polysome preparation necessary 
for optimal in^ vitro translation in a 25 ul translation mixture, 1, 2, 
3, 4 and 5 ul aliquots were employed. Figure 3 shows that optimum 
incorporation of radioactivity using free polysomal preparations was 
achieved using 2 ul samples. Experimental titrations of membrane bound 
polysomal preparations indicated that maximum efficiency was achieved 
using 3 ul samples (Fig 3). All subsequent i_n vitro translations were 
performed using 2 and 3 ul aliquots of free and membrane bound polysomes, 
respectively.     
Ouchterlony Immunodiffusion Assays 
Ouchterlony immunodiffusion was employed in order to determine 
homology between rabbit anti-chick brain hyaluronidase anti-serum and 
and cytosolic and lysosomal preparations. Figure 4 shows that a pre¬ 
cipitin band was formed between antiserum and both cytosolic and lyso¬ 
somal fractions (100 ug) but not with wells containing saline. Anti¬ 
serum was then used in immunoprécipitation experiments to detect the 
presence of hyaluronidase in translation mixtures with both free and 
membrane bound polysomes as the RNA source. 
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Figure 3. Incorporation of~^5S-Methfonine radioactivity into 
protein using free and membrane bound polysomes. 
Incorporation was measured in counts per minute. 
Dotted line represents aliquots of free polysomal 





Figure 4. Ouchterlony immunodiffusion assay. Center well contains 
rabbit anti-chick brain hyaluronidase antiserum (40 ul). 
Wells land 2 contain saline. Wells 3 and 4 contain 
cytosolic fraction (200 ul). Wells 5 and 6 contain 




In vitro translation using free polysomes followed by immunopreci- 
tation yielded a 72,000 dalton MW polypeptide (Figure 5, lane 2), while 
in vitro translation using membrane bound polysomes yielded a 69,000 
dalton Mw polypeptide (Figure 5, lane 6). In order to determine whether 
or not the 72 K polypeptide was a precursor form of the authentic poly¬ 
peptide, stripped dog pancreatic microsomal membrane (DPM) was added 
cotranslationally to jn_ vitro translation mixtures with free polysomes 
as the source of mRNA. This preparation yielded a 72K polypeptide also 
(Figure 5, lane 3). Post-translational proteolysis of the free polysome 
and free polysome plus DPM showed a disappearance of the 72K band (Figure 
5, lanes 4 and 5). These results indicate that insertion of the nascent 
polypeptide into the lumen of the endoplasmic reticulum could not 
have occurred. Treatment of the membrane bound polysomes with proteases, 
post-translationally, showed that the 69K polypeptide was partially 
protected against the proteases (Figure 5, lane 7). The results strongly 
suggest that the free and membrane polysomes synthesize two hyaluroni- 
dases of different molecular weights. 
Figure 5. Fluorograph of in vitro translation products following 
immunoprécipitation. Lane 1. Molecular weight mark¬ 
er. Lane 2. Free polysomes. Lane 3. Free polysomes 
plus DPM. Lane 4. Free polysomes plus DPM plus tryp¬ 
sin and chymotrypsin. Lane 5. Free polysomes plus 
trypsin and chymotrypsin. Lane 6. Membrane bound 
polysomes. Lane 7. Membrane bound polysomes plus 
trypsin and cymotrypsin. 
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Isolation Of Hyaluronidase From Cytosolic and Lysosomal Fractions 
Isolation of hyaluronidase from the cytosolic fraction was perform¬ 
ed in order to determine whether or not a form of the enzyme synthesized 
on free polysomes is vectored into the cytoplasm and thus present in the 
cytosolic fractions. Subcellular fractionation followed by ammonium 
sulfate precipitation and subsequent Concanavalin A Sepharose chromato¬ 
graphy yielded a 72 K and a 70 K polypeptide (Figure 6 lane 1 and Figure 7 
lane 5). Fractions containing these polypeptides exhibited hyaluronidase 
activity. 
Enzymatic Assay For Hyaluronidase Activity 
Crude cytosolic and lysosomal fractions exhibited hyaluronidase 
activity (Figures 8 and 9). In all assays hyaluronidase activity remained 
linear for approximately 8 hours. Table 1 indicates the specific acti¬ 
vity exhibited by crude and ammonium sulfate precipitated fractions after 
Concanavalin A sepharose chromatography. Concanavalin A Sepharose fractions 
showed a 338 and 503 fold increase in specific activity over the crude 
cytosolic and lysosomal fractions, respectively. 
Gel electrophoresis and Molecular Weight 
Determinations Of Isolated Hyaluronidase 
Concanavalin A sepharose fractions (bound and unbound) were run 
on 10% SDS polyacrylamide gels. The cytosolic fraction which was 
ammonium sulfate precipitated yielded a 72K and a 70K polypeptide that 
Figure 6. SDS polyacrylamide gel electrophoresis of 65% 
ammonium sulfate precipitates following con- 
canavalin A sepharose chromatography (from 
cytosolic fraction). Lane 1. non binding 
fraction Lane 2. binding fraction. 
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Figure 7. SDS polyacrylamide gel electrophoresis (10%) of 65% 
ammonium sulfate precipitated fractions (from 
lysosomal fraction) following concanavalin a sepha- 
rose chromatography. Lane 1 Marker Lane 2 and 3 
non binding fraction. Lane 4. binding fraction. 
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Figure 8. Enzymatic activity of crude cytosolic fraction. Assays 
were routinely carried out for 8 hrs at 37°C. Controls 











Figure 9. Enzymatic activity of crude lysosomal fraction, Assays 
were carried out for 8 hrs at 37°C. Controls were 






Table 1. Isolation of hyaluronidase from cytosolic and lysomal fractions 
Ug N-acetyl- 
glucosamine 
released/ mg/ Specific Fold 
Fraction min protein Activity* Purity 
Crude cytosol 1.40 1.89 0.740 1 
Crude lysosome 1.13 1.69 0.671 1 
35% (AMS) Cytosol 
(con A Non binding) 5.52 0.021 262 354.1 
65% (AMS) Lysosomal 
(Con A binding) 5.08 0.015 338 503.7 
♦Specific activity is measured in Ug N-acetylglucosamine released per min 
at 37°C per mg protein 
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were unable to bind to the concanavilin A sepharose column. The 70 K 
polypeptide, however, was also present in the binding fraction. This 
result indicates that the 70 K protein may be glycosylated and its appear¬ 
ance in the non binding fraction was due to some type of interaction that 
causes the two proteins to co-mi grate in vitro. Concanavalin A sepharose 
chromatography of the ammonium sulfate precipitated lysosomal fraction 
yielded a 72K MW and 70 K MW polypeptide in the binding fraction only. 
This suggests that the polypeptides in the lysosomal fraction are gly¬ 
cosylated (Figure 7 lane 4). The 72K MW protein, however, is also present 
in the lysosomal fraction, which also suggests some type of interaction. 
CHAPTER V 
DISCUSSION 
In vitro translation using free polysomes and rough microsomes 
(membrane-bound polysomes) has been previously described (Erickson and 
Blobel, 1979). Free polysomes, defined as polyribosomes not attached to 
membrane, provide a unique source of mRNA and are initially devoid of 
membrane during subcellular fractionation because of their lack of a 
putative hydrophobic signal sequence (Blobel and Dobberstein 1975). This 
aminoterminal sequence is said to be responsible for the binding of 
polyribosomes carrying the signal, to the membrane of the endoplasmic 
reticulum (Walter and Blobel, 1980). Membrane-bound polysomes alter¬ 
natively have the signal sequence and synthesize proteins which 
need no further translocation or co-translational apparatus. Rough 
microsomes is the functional term for fractionated endoplasmic reticulum 
with ribosomes attached. These rough microsomes are functional units 
that are able to carry out protein synthesis and vectorial discharge 
into the microsomal lumen (Adelman and Blobel, 1980; Amar-Costesec et al, 
1974; Kreibich et^ ctl_, 1981). Synthesis of proteins on membrane-bound 
polysomes is characteristic of many membrane proteins and most secretory 
proteins. Free polysomes however; synthesize soluble or cytosolic pro¬ 
teins (Blobel, 1980; Kreibich et al_, 1980). 
In vitro synthesis of embryonic chick brain hyaluronidase using 
both free and membrane bound polysomes produced two different forms of 
the enzyme. One form is synthesized on free polysome and is presumed to 
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be cytosolic. The other form is synthesized on membrane bound polysomes 
and vectored through the endomembrane system in route to its ultimate 
destination in the lysosomes. Both translation using free polysomes 
and free polysomes in the presence of dog pancreatic membrane followed 
by immunoprécipitation with monospecific antisera yielded polypeptides 
of the same molecular weight. This occurrence at first led us to believe 
that the polypeptide (72K) was a pre-protein based on the fact that the 
free polysome preparation probably contained ribosomes that were detach¬ 
ed during subcellular fraction from the endoplasmic reticulum. Thus 
the pre-protein was, presumably, inserted into the endoplasmic reticulum. 
However, a shift in molecular weight was not observed. One explanation 
for this occurrence could be that a shortening due to a loss of a 
signal sequence was hidden by core glycosylation of asparagine-linked 
oligosaccharide chains (Rosenfeld et al_, 1982). To determine whether 
this was the case we added proteases (trypsin and chymo-trypsin) post- 
translational ly. We observed a disappearance of the 72K MW polypeptide 
in both free polysome and free polysome plus DPM translation mixtures. 
This result indicated that insertion into the endoplasmic reticulum 
could not have occurred since the dog pancreatic microsomal membrane 
was incapable of protecting the newly synthesized polypeptide. Membrane- 
bound polysomes, at least partially, protected the 69K polypeptide from 
the action of the proteases. This is most probably due to the ability 
of the chicks endogenous microsomal membrane to foster the translocation 
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of the nascent polypeptide chain into the lumen of the endoplasmic 
reticulum. 
Isolation of the enzyme from its putative sites of function gave 
interesting results. Both the cytosol and lysosomal fractions yielded a 
72K and a 70K MW polypeptide. Isolation from the lysosomal fraction 
also yielded a 70K and 72K MW polypeptide. The 70 K MW protein, being 
slightly higher than the 69K observed i_n^ vitro, is most likely due to 
the fact that lysosomal enzymes have been shown to follow the same pro¬ 
cessing pathway as secretory and membrane proteins. Presuming this is 
the current acceptable pathway, hyaluronidase j_n vivo must be vector¬ 
ed through the golgi apparatus, where terminal glycosylation takes place. 
This would account for the slight difference in molecular weight observed 
between the in_ vivo and i_n vitro forms. 
Isolation of hyaluronidase from the cytosolic and lysosomal fractions 
yielded two proteins of 72K and 70 K MW. The cytosolic fraction yielded 
the protein in the non-binding concanavalin A sepharose fraction, which 
strongly suggested that the 2 proteins were not glycosylated. The same 
70 K MW protein, however, was, also present in the binding con A sepharose 
fraction, indicating that the 70K polypeptide was glycosylated. This 
led us to question why the 70K MW protein would also be present in the 
non-binding fraction. One explanation for this occurrence is that in 
vitro the two forms somehow interact with one another. This interaction 
may cause them to bind to each other during the fractionation and isolation 
process. When this complex is placed on the con A column, some of the 
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glycosylated protein (70K) is bound to the non-glycosylated protein. 
Another possible explanation is that the carbohydrate moieties of this 
protein may somehow be shielded from the concanavalin A sepharose. The 
majority of the glycosylated protein is, however, still separated from 
the complex and thus binds to the column. This suggests that the 
proposed interaction, if present, is most probably a weak one. Isolation 
of the enzyme from the lysosomal fraction seems to somewhat support this 
hypothesis. The lysosomal fraction also yielded a 72K and a 70K protein 
present in the concanavalin A sepharose binding fraction. This inter¬ 
action between the two forms may have occurred again; the nonglycosylated 
protein (72K) appears to be glycosylated. Thus, the two proteins again 
comigrate and appear in the binding fraction. In both cases when the 
proteins are prepared for gel electrophoresis the interaction is broken 
and the polypeptides migrate according to their own molecular weights. 
Isoenzymes of lysosomal proteins have been shown previously (Kanfer 
et^ al_, 1975, Glew et al_, 1976). Cytosolic and lysosomal forms of various 
lysosomal enzymes have been reported and in many cases been to be immuno- 
logically cross reactive. 
The existence of two forms of hyaluronidase raises interesting 
questions as to the possible function of the cytosolic form. One 
of which is that a cytosolic form may degrade endogenous substrate 
that has not yet been in contact with primary lysosomes. Another 
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possibility is that the cytosolic form is a receptor for hyaluronic acid 
and thereby complexes with lysosomal hyaluronidase inside the cell. 
One other possibility is that the cytosolic form regulates the action 
of the lysosomal form by interacting with it at an appropriate time 
in development. Our data suggests that the cytosolic form of hyaluroni¬ 
dase interacts with the lysosomal form i_n vitro and presumably 1n_ vivo. 
The fact that the cytosolic form is not glycosylated and undergoes no 
co-translational or post translational processing confirms the separate 
distribution of the two forms. However, the close proximity between the 
lysosomal and cytoplasmic enzymes would allow for the type of inter¬ 
action necessary for enzymatic regulation. 
CHAPTER VI 
SUMMARY 
1. Embryonic chick brain hyaluronidase is synthesized on free poly¬ 
somes, and is approximately 72,000 daltons. 
2. Chick brain hyaluronidase is also synthesized on membrane bound 
polysomes and has a molecular weight of 69,000 daltons. 
3. The form synthesized on free polysomes is not glycosylated and 
is present in the cytosolic fraction. 
4. The enzyme present in the lysosomal fraction is glycosylated and 
is synthesized on membrane bound polysomes. 
5. There may be some interaction between the two forms in vitro, 
causing them to co-mi grate on a Concanavalin A sepharose column. 
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